Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA
/PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a leader in sickle cell disease treatment, announced today that it has received a Medicine...
Source: prnewswire.com